BARBARA ANN KARMANOS CANCER INSTITUTE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2006–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	3	1
2024	—	3	1
2023	—	4	1
2022	—	8	2
2021	—	8	2
2020	—	8	2
2019	—	7	2
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	4	1
2007	—	2	1
2006	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE FRANKLIN PARTNERSHIP	—	77
MANATOS & MANATOS	—	15

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	76
SENATE	76
Health & Human Services, Dept of (HHS)	62
Centers For Medicare and Medicaid Services (CMS)	61
Defense, Dept of (DOD)	60

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	78
Medicare/Medicaid	Medicare/Medicaid	69
Health Issues	Health Issues	63
Budget/Appropriations	Budget/Appropriations	63

BARBARA ANN KARMANOS CANCER INSTITUTE — Lobbying Disclosure | Poliscope